Dr. Barry Bochner, President, CEO and CSO at Biolog, Inc. in Hayward, California, has a broad background and diverse interests in cell physiology and metabolic analysis. Dr. Bochner's educational background includes B.S. and M.S. degrees from MIT and a Ph.D. in Bioengineering from University of Michigan. This was followed by postdoctoral work in Biochemistry at the University of California at Berkeley. Prior to co-founding Biolog, Inc., he was a Senior Scientist at Genentech, Inc. heading a group in microbial physiology.
Lars Angenent, Ph.D
Department of Energy, Environmental & Chemical Engineering
Washington University in St. Louis
Title: Conversion of Wastewater into Bioenergy
Phil Dennis, MA. Sc.
Technology Manager
SiREM Inc.,
Title: Dehalococcoides, Getting to Know Our Closest Ally in Remediation of Chlorinated Compounds
Phil Dennis holds a Masters of Applied Science in Civil Engineering, from the University of Toronto and a Bachelors degree in Molecular Biology and Genetics from the University of Guelph. Phil has over 16 years of research and laboratory experience pertaining to molecular biology, microbiology and environmental remediation. Phil has performed in a managerial capacity for 6 years, at SiREM, an industry leader in bioaugmentation and testing related to bioremediation. Phil currently manages SiREM's molecular biology program, technical marketing and research and development. Phil over saw the implementation of one of the first commercial Dehalococcoides testing services and participated in the production scale-up and commercialization of a leading Dehalococcoides
bioaugmentation culture (KB-1).
Laurie A. Achenbach, PhD.
Professor
Dept. of Microbiology & Interim Assoc. Dean for Research and Graduate Affairs, College of Science
Southern Illinois University, Carbondale, IL
Title: (Per)Chlorate Reducing Bacteria
Dr. Laurie A. Achenbach received her B.S. in biology from Northern Michigan University in Marquette where she majored in biology and physics. She then went on to receive her Ph.D. from the University of Illinois at Urbana-Champaign for research on the evolutionary relationships of hyperthermophilic organisms working under the direction of Carl Woese, the discoverer of the third domain of life, the Archaea. Following a year in Japan and a two-year postdoctoral position, she joined the faculty at Southern Illinois University Carbondale in 1990 where she is a Full Professor in the Department of Microbiology. Her work has resulted in over 50 scientific publications, numerous articles in the popular press, and several local television interviews. Her work is currently funded by the U.S. Department of Energy, the U.S. Department of Defense, and the U.S. Department of Agriculture.
Brad Stawick, M.S.
President and Technical Director
Stawick Laboratory Management, LLC, Bartlett, TN
Title: Considerations in Selection of a Contract Laboratory
Mr. Stawick is President and Technical Director of Stawick Laboratory Management, a laboratory and food safety consulting firm. He has over 15 years of experience in performing quality assurance, safety, process improvement, and microbiological testing, including traditional cultural methods, ELISA, PCR, and serological techniques. Mr. Stawick has worked for two major testing laboratories in many capacities including Laboratory Director, Corporate Director of Quality and Safety, and Chief Microbiologist. He has experience with GMP, GLP, AOAC, FDA requirements, laboratory accreditation, automation, and process improvements. Mr. Stawick holds a Masters of Science degree in Food Science and a Bachelor of Science degree in Biology, both from the University of Illinois at Urbana.
Bruce Clark Hemming, Ph.D.
President and CEO
Microbe Inotech Laboratories, Inc.
Dr. Hemming is an accomplished science and business professional with over 30 years of real-world experience in microbiology and its practical applications. In 1982 he received his doctorate in Plant Pathology from Montana State University, Bozeman. His Bachelor's degree in Microbiology and Master's degree in Biochemistry are both from Brigham Young University, Provo, UT. He is the founder and president of Microbe Inotech Laboratories, which is now in its 16th year of business.
As an educator he served as an adjunct professor at St. Louis University as well as University of Missouri St. Louis and as a visiting faculty member for the Institute for Genetics Education at the University of Wisconsin. He currently serves on three biotechnology committees for local Universities and Colleges.
During his ten years at Monsanto Corporation Dr. Hemming was responsible for multi-disciplinary teams involved in original research. He earned several patents on his research within the field of microbiology. He was charged with the development of creative exploratory research within crop protection technology with a focus on biological control and microbial genetics and served as Biocontrol Project Leader in the development of biofungicides in conjunction with CSIRO Division of Soils (Australia) and State Universities in the U.S.A. Project coordinator of a multi-disciplinary research team working toward the development of biofungicides. His responsibility included the development of collaborative agreements, preparation of regulatory documents, microbial physiology and tracking studies, coordination of the natural product/gene discovery effort, and field trials of various projects, which included the first introduction into the environment in the U.S.A. of genetically engineered bacteria containing foreign genes.
Dr. Hemming has received many honors and awards related to his work and research, which has included being selected as a Ralph M. Johnson distinguished guest lecturer and has presented his work in Austria, England, France, Germany, Israel, Japan, Yugoslavia and US universities. He is the author of more than forty peer reviewed scientific journals and industrial publications.
